These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20375592)

  • 21. A trio of microRNAs that control Toll-like receptor signalling.
    Quinn SR; O'Neill LA
    Int Immunol; 2011 Jul; 23(7):421-5. PubMed ID: 21652514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innate immunity and toll-like receptors: clinical implications of basic science research.
    Abreu MT; Arditi M
    J Pediatr; 2004 Apr; 144(4):421-9. PubMed ID: 15069387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukocyte toll-like receptor expression in end-stage kidney disease.
    Gollapudi P; Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
    Am J Nephrol; 2010; 31(3):247-54. PubMed ID: 20090311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms of the Toll-like receptors and human disease.
    Schwartz DA; Cook DN
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S403-7. PubMed ID: 16237638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cracking the Toll-like receptor code in fungal infections.
    Cunha C; Romani L; Carvalho A
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1121-37. PubMed ID: 20954879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Toll-like receptor gene polymorphisms to tuberculosis susceptibility in humans.
    Thada S; Valluri VL; Gaddam SL
    Scand J Immunol; 2013 Sep; 78(3):221-9. PubMed ID: 23672492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Toll-like receptors and the significance for clinical medicine].
    Wiersinga WJ; van der Poll T
    Ned Tijdschr Geneeskd; 2005 May; 149(21):1150-5. PubMed ID: 15940918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
    Sukkar MB; Xie S; Khorasani NM; Kon OM; Stanbridge R; Issa R; Chung KF
    J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential induction of Toll-like receptor gene expression in equine monocytes activated by Toll-like receptor ligands or TNF-α.
    Kwon S; Vandenplas ML; Figueiredo MD; Salter CE; Andrietti AL; Robertson TP; Moore JN; Hurley DJ
    Vet Immunol Immunopathol; 2010 Dec; 138(3):213-7. PubMed ID: 20801527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk.
    Nieters A; Beckmann L; Deeg E; Becker N
    Genes Immun; 2006 Dec; 7(8):615-24. PubMed ID: 16971956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptors.
    Lien E; Ingalls RR
    Crit Care Med; 2002 Jan; 30(1 Suppl):S1-11. PubMed ID: 11782555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors.
    O'Neill LA; Dunne A; Edjeback M; Gray P; Jefferies C; Wietek C
    J Endotoxin Res; 2003; 9(1):55-9. PubMed ID: 12691620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of Toll-like receptors in regulation of immune responses in norm and pathology].
    Spivak NIa; Bogdanova IM; Martirosova NI; Malaĭtsev VV
    Fiziol Zh (1994); 2008; 54(6):87-99. PubMed ID: 19227245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of toll-like receptors in human diseases.
    Montero Vega MT; de Andrés Martín A
    Allergol Immunopathol (Madr); 2009; 37(5):252-63. PubMed ID: 19853360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptors, endogenous ligands, and systemic autoimmune disease.
    Rifkin IR; Leadbetter EA; Busconi L; Viglianti G; Marshak-Rothstein A
    Immunol Rev; 2005 Apr; 204():27-42. PubMed ID: 15790348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLRs and chronic inflammation.
    Ospelt C; Gay S
    Int J Biochem Cell Biol; 2010 Apr; 42(4):495-505. PubMed ID: 19840864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innate immunity, Toll-like receptors, and atherosclerosis: mouse models and methods.
    Sorrentino R; Arditi M
    Methods Mol Biol; 2009; 517():381-99. PubMed ID: 19378021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional characterization of naturally occurring genetic variants in the human TLR1-2-6 gene family.
    Ben-Ali M; Corre B; Manry J; Barreiro LB; Quach H; Boniotto M; Pellegrini S; Quintana-Murci L
    Hum Mutat; 2011 Jun; 32(6):643-52. PubMed ID: 21618349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple roles of Toll-like receptor signaling in atherosclerosis.
    Björkbacka H
    Curr Opin Lipidol; 2006 Oct; 17(5):527-33. PubMed ID: 16960501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.
    Arranz A; Juarranz Y; Leceta J; Gomariz RP; Martínez C
    Peptides; 2008 Jun; 29(6):948-56. PubMed ID: 18359536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.